Progenics Pharmaceuticals (PGNX)

Add to Watchlists
Create an Alert
4.80 +0.12  +2.56% NASDAQ Oct 20, 5:00PM BATS Real time Currency in USD

Progenics Pharmaceuticals Enterprise Value:

240.17M for Oct. 17, 2014

View 4,000+ financial data types

View Full Chart

Progenics Pharmaceuticals Enterprise Value Chart

Export Data
Save Image

Progenics Pharmaceuticals Historical Enterprise Value Data

View and export this data going back to 1997. Start your Free Trial
Export Data Date Range:
Viewing of   First  Previous First  Previous   Next  Last Next   Last
Data for this Date Range  
Oct. 17, 2014 240.17M
Oct. 16, 2014 252.00M
Oct. 15, 2014 237.39M
Oct. 14, 2014 237.39M
Oct. 13, 2014 223.48M
Oct. 10, 2014 226.96M
Oct. 9, 2014 231.13M
Oct. 8, 2014 243.65M
Oct. 7, 2014 245.74M
Oct. 6, 2014 256.87M
Oct. 3, 2014 275.99M
Oct. 2, 2014 265.21M
Oct. 1, 2014 261.74M
Sept. 30, 2014 275.65M
Sept. 29, 2014 279.82M
Sept. 26, 2014 285.38M
Sept. 25, 2014 272.17M
Sept. 24, 2014 279.12M
Sept. 23, 2014 256.87M
Sept. 22, 2014 254.78M
Sept. 19, 2014 268.00M
Sept. 18, 2014 277.73M
Sept. 17, 2014 284.69M
Sept. 16, 2014 276.34M
Sept. 15, 2014 272.86M
   
Sept. 12, 2014 281.21M
Sept. 11, 2014 291.64M
Sept. 10, 2014 290.95M
Sept. 9, 2014 284.69M
Sept. 8, 2014 295.12M
Sept. 5, 2014 288.17M
Sept. 4, 2014 295.82M
Sept. 3, 2014 299.30M
Sept. 2, 2014 301.38M
Aug. 29, 2014 297.90M
Aug. 28, 2014 283.30M
Aug. 27, 2014 292.34M
Aug. 26, 2014 293.04M
Aug. 25, 2014 283.99M
Aug. 22, 2014 286.08M
Aug. 21, 2014 270.78M
Aug. 20, 2014 274.95M
Aug. 19, 2014 279.82M
Aug. 18, 2014 265.91M
Aug. 15, 2014 261.74M
Aug. 14, 2014 262.43M
Aug. 13, 2014 263.13M
Aug. 12, 2014 236.00M
Aug. 11, 2014 238.78M
Aug. 8, 2014 236.70M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About Enterprise Value

Click "Learn More" below to see how YCharts calculates Enterprise Value.

Enterprise Value (EV) is a valuation metric alternative to traditional market capitalization that reflects the market value of an entire business. Like market cap, EV is a measure of what the market believes a company is worth. Enterprise value captures the cost of an entire business, including debt and equity. It is a sum of claims of all preferred shareholders, debt holders, security holders, common equity holders, and minority shareholders - unlike market cap, which only captures the total value of common equity securities.

EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Learn More

Get data for
Advertisement

PGNX Enterprise Value Benchmarks

Companies
Salix Pharmaceuticals 11.31B
Seattle Genetics 3.928B
AMAG Pharmaceuticals 450.68M

PGNX Enterprise Value Range, Past 5 Years

Minimum 9.441M Nov 11 2009
Maximum 362.35M Jan 17 2014
Average 155.76M

PGNX Enterprise Value Excel Add-In Codes

  • Metric Code: enterprise_value
  • Latest data point: =YCP("PGNX", "enterprise_value")
  • Last 5 data points: =YCS("PGNX", "enterprise_value", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.

Advertisement

You've hit the 10 page limit on YCharts.

Experience the power of YCharts Professional.
Start your Free 14-Day Trial.

Start My Free Trial No credit card required.

Already a subscriber? Sign in.

{{root.upsell.info.feature_headline}}.

{{root.upsell.info.feature_description}}
Start your free 14 Day Trial.

{{root.upsell.info.button_text}} No credit card required.

Already a subscriber? Sign in.